1,276
Views
14
CrossRef citations to date
0
Altmetric
Review Article

Dimethyltryptamine: Endogenous Role and Therapeutic Potential

, &
Pages 299-310 | Received 06 Aug 2018, Accepted 01 Feb 2019, Published online: 25 Apr 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Robson Savoldi, Antonio Roazzi & Rita Clara de Oliveira Sales. (2023) Mystical and Ego-Dissolution Experiences in Ayahuasca and Jurema Holistic Rituals: An Exploratory Study. The International Journal for the Psychology of Religion 33:4, pages 332-360.
Read now

Articles from other publishers (13)

Lucas Cruz, Bheatrix Bienemann, Fernanda Palhano-Fontes, Luís Fernando Tófoli, Dráulio B. Araújo & Daniel C. Mograbi. (2023) A quantitative textual analysis of the subjective effects of ayahuasca in naïve users with and without depression. Scientific Reports 13:1.
Crossref
Emma Eckernäs, Jeroen Koomen, Christopher Timmermann, Robin Carhart‐Harris, Daniel Röshammar & Michael Ashton. (2023) Optimized infusion rates for N,N‐dimethyltryptamine to achieve a target psychedelic intensity based on a modeling and simulation framework. CPT: Pharmacometrics & Systems Pharmacology 12:10, pages 1398-1410.
Crossref
Carla Soares, Gerardo Gonzalo, João Castelhano & Miguel Castelo-Branco. (2023) The relationship between the default mode network and the theory of mind network as revealed by psychedelics – A meta-analysis. Neuroscience & Biobehavioral Reviews 152, pages 105325.
Crossref
Pascal Michael, David Luke & Oliver Robinson. (2023) An encounter with the self: A thematic and content analysis of the DMT experience from a naturalistic field study. Frontiers in Psychology 14.
Crossref
Matteo Politi, Giorgia Tresca, Luigi Menghini & Claudio Ferrante. (2021) Beyond the Psychoactive Effects of Ayahuasca: Cultural and Pharmacological Relevance of Its Emetic and Purging Properties. Planta Medica 88:14, pages 1275-1286.
Crossref
Alessandro M. Varani, Saura R. Silva, Simone Lopes, Jose Beethoven Figueiredo Barbosa, Danilo Oliveira, Maria Alice Corrêa, Ana Paula Moraes, Vitor F.O. Miranda & Francisco Prosdocimi. (2022) The complete organellar genomes of the entheogenic plant Psychotria viridis (Rubiaceae), a main component of the ayahuasca brew . PeerJ 10, pages e14114.
Crossref
Steven A. Barker. (2022) Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT. Psychopharmacology 239:6, pages 1749-1763.
Crossref
Edward James, Joachim Keppler, Thomas L Robertshaw & Ben Sessa. (2022) N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine. Human Psychopharmacology: Clinical and Experimental 37:3.
Crossref
Bruno Gianfratti, Ricardo Tabach, Marna Eliana Sakalem, Talita Stessuk, Lucas Oliveira Maia & Elisaldo Araujo Carlini. (2022) Ayahuasca blocks ethanol preference in an animal model of dependence and shows no acute toxicity. Journal of Ethnopharmacology 285, pages 114865.
Crossref
Jerome Sarris, Diego Pinzon Rubiano, Kimberley Day, Nicole L. Galvão-Coelho & Daniel Perkins. (2022) Psychedelic medicines for mood disorders: current evidence and clinical considerations. Current Opinion in Psychiatry 35:1, pages 22-29.
Crossref
Pascal Michael, David Luke & Oliver Robinson. (2021) An Encounter With the Other: A Thematic and Content Analysis of DMT Experiences From a Naturalistic Field Study. Frontiers in Psychology 12.
Crossref
Daniel Perkins, Jerome Sarris, Susan Rossell, Yvonne Bonomo, David Forbes, Christopher Davey, Daniel Hoyer, Colleen Loo, Greg Murray, Sean Hood, Violeta Schubert, Nicole Leite Galvão-Coelho, Meaghen O’Donnell, Olivia Carter, Paul Liknaitzky, Martin Williams, Dan Siskind, David Penington, Michael Berk & David Castle. (2021) Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm. Australian & New Zealand Journal of Psychiatry 55:12, pages 1127-1133.
Crossref
Gniewko Więckiewicz, Iga Stokłosa, Magdalena Piegza, Piotr Gorczyca & Robert Pudlo. (2021) Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review. Pharmaceuticals 14:8, pages 793.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.